130 related articles for article (PubMed ID: 1692638)
1. [Measurement of intestinal permeability in Crohn's disease, ulcerative colitis, sprue and idiopathic hyperamylasemia using polyethyleneglycol-400].
Zellweger U; Freiburghaus AU; Münch R; Meyenberger C; Bühler H; Ammann R
Schweiz Med Wochenschr; 1990 Apr; 120(17):617-20. PubMed ID: 1692638
[TBL] [Abstract][Full Text] [Related]
2. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400.
Jenkins RT; Goodacre RL; Rooney PJ; Bienenstock J; Sivakumaran T; Walker WH
Clin Biochem; 1986 Oct; 19(5):298-302. PubMed ID: 3769195
[TBL] [Abstract][Full Text] [Related]
3. [Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS)].
Ott M; Lembcke B; Staszewski S; Helm EB; Caspary WF
Klin Wochenschr; 1991 Oct; 69(15):715-21. PubMed ID: 1795495
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.
Munkholm P; Langholz E; Hollander D; Thornberg K; Orholm M; Katz KD; Binder V
Gut; 1994 Jan; 35(1):68-72. PubMed ID: 8307453
[TBL] [Abstract][Full Text] [Related]
5. Intestinal permeability in patients with Crohn's disease and their first degree relatives.
Teahon K; Smethurst P; Levi AJ; Menzies IS; Bjarnason I
Gut; 1992 Mar; 33(3):320-3. PubMed ID: 1568650
[TBL] [Abstract][Full Text] [Related]
6. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
Heuman R; Sjödahl R; Tagesson C
Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
[TBL] [Abstract][Full Text] [Related]
7. PEG-400 excretion in patients with Crohn's disease, their first-degree relatives, and healthy volunteers.
Ruttenberg D; Young GO; Wright JP; Isaacs S
Dig Dis Sci; 1992 May; 37(5):705-8. PubMed ID: 1563311
[TBL] [Abstract][Full Text] [Related]
8. Neopterin concentration as an index of disease activity in Crohn's disease and ulcerative colitis.
Husain N; Tokoro K; Popov JM; Naides SJ; Kwasny MJ; Buchman AL
J Clin Gastroenterol; 2013 Mar; 47(3):246-51. PubMed ID: 23269308
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary functional disorders in ulcerative colitis and Crohn's disease].
Sommer H; Schmidt M; Gruber KD
Dtsch Med Wochenschr; 1986 May; 111(21):812-5. PubMed ID: 3698863
[TBL] [Abstract][Full Text] [Related]
11. Measurement of intestinal permeability using 51Cr-EDTA.
Peled Y; Watz C; Gilat T
Am J Gastroenterol; 1985 Oct; 80(10):770-3. PubMed ID: 3929593
[TBL] [Abstract][Full Text] [Related]
12. [Hyperamylasemia, hyperlipasemia and acute pancreatitis in chronic inflammatory bowel diseases].
Tromm A; Höltmann B; Hüppe D; Kuntz HD; Schwegler U; May B
Leber Magen Darm; 1991 Jan; 21(1):15-6, 19-22. PubMed ID: 1709251
[TBL] [Abstract][Full Text] [Related]
13. Intestinal permeability in gastrointestinal disorders. Use of oral [99mTc]DTPA.
Resnick RH; Royal H; Marshall W; Barron R; Werth T
Dig Dis Sci; 1990 Feb; 35(2):205-11. PubMed ID: 2406112
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
[TBL] [Abstract][Full Text] [Related]
15. Increased permeability of macroscopically normal small bowel in Crohn's disease.
Peeters M; Ghoos Y; Maes B; Hiele M; Geboes K; Vantrappen G; Rutgeerts P
Dig Dis Sci; 1994 Oct; 39(10):2170-6. PubMed ID: 7924738
[TBL] [Abstract][Full Text] [Related]
16. Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor.
Hollander D; Vadheim CM; Brettholz E; Petersen GM; Delahunty T; Rotter JI
Ann Intern Med; 1986 Dec; 105(6):883-5. PubMed ID: 3777713
[TBL] [Abstract][Full Text] [Related]
17. Hyperamylasemia in inflammatory bowel disease.
Katz S; Bank S; Greenberg RE; Lendvai S; Lesser M; Napolitano B
J Clin Gastroenterol; 1988 Dec; 10(6):627-30. PubMed ID: 2466072
[TBL] [Abstract][Full Text] [Related]
18. Serum lysozyme in Crohn's disease and ulcerative colitis.
Helman CA; Novis BH; Bank S; Wormold L; Jacobs P
S Afr Med J; 1977 Dec; 52(26):1042-4. PubMed ID: 609977
[TBL] [Abstract][Full Text] [Related]
19. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease.
Casellas F; Aguadé S; Soriano B; Accarino A; Molero J; Guarner L
Am J Gastroenterol; 1986 Sep; 81(9):767-70. PubMed ID: 3529937
[TBL] [Abstract][Full Text] [Related]
20. Autonomic cardiovascular regulation in quiescent ulcerative colitis and Crohn's disease.
Coruzzi P; Castiglioni P; Parati G; Brambilla V; Brambilla L; Gualerzi M; Cademartiri F; Franzè A; De Angelis G; Di Rienzo M; Di Mario F
Eur J Clin Invest; 2007 Dec; 37(12):964-70. PubMed ID: 18036030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
